Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance
Authors
Keywords
B cell receptor signaling, Lyn, bortezomib resistance, mantle cell lymphoma, dasatinib
Journal
Oncotarget
Volume 6, Issue 35, Pages -
Publisher
Impact Journals, LLC
Online
2015-10-27
DOI
10.18632/oncotarget.5425

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.